Literature DB >> 13664785

The maintenance of a sustained thrombolytic state in man. I. Induction and effects.

A P FLETCHER, N ALKJAERSIG, S SHERRY.   

Abstract

Entities:  

Keywords:  STREPTODORNASE AND STREPTOKINASE/therapeutic use; THROMBOEMBOLISM/therapy

Mesh：

Substances：

Year:  1959        PMID： 13664785      PMCID： PMC293257          DOI： 10.1172/JCI103886

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  26 in total

1.  Studies on enhanced fibrinolytic activity in man.

Authors:  S SHERRY; R I LINDEMEYER; A P FLETCHER; N ALKJAERSIG
Journal:  J Clin Invest       Date:  1959-05       Impact factor: 14.808

2.  Clotting deviations in man during cardiac bypass: fibrinolysis and circulating anticoagulant.

Authors:  K N VON KAULLA; H SWAN
Journal:  J Thorac Surg       Date:  1958-10

3.  Chronic antithrombinaemia (Antithrombin V) with Haemorrhagic diathesis in a case of rheumatoid arthritis with hypergammaglobulinaemia).

Authors:  A LOELIGER; J F HERS
Journal:  Thromb Diath Haemorrh       Date:  1957-12-15

4.  Biochemical experimental, and clinical studies of proteolytic enzymes with particular reference to the fibrinolytic enzyme of human plasma.

Authors:  S SHERRY; N ALKJAERSIG
Journal:  Ann N Y Acad Sci       Date:  1957-08-30       Impact factor: 5.691

5.  Effects in patients of intravenous infusions of purified streptokinase preparations.

Authors:  A J JOHNSON; A P FLETCHER; W R MCCARTY; W S TILLETT
Journal:  Proc Soc Exp Biol Med       Date:  1957-02

6.  Methods employed for purification of streptokinase.

Authors:  A P FLETCHER; A J JOHNSON
Journal:  Proc Soc Exp Biol Med       Date:  1957-01

7.  The enzymatic dissolution of experimental arterial thrombi in the dog by trypsin, chymotrypsin and plasminogen activators.

Authors:  S SHERRY; A TITCHENER; L GOTTESMAN; P WASSERMAN; W TROLL
Journal:  J Clin Invest       Date:  1954-10       Impact factor: 14.808

8.  Fibrinolytic activity of human blood after death.

Authors:  S MULLERTZ
Journal:  Acta Physiol Scand       Date:  1952

9.  An antithrombin reaction to prothrombin activation.

Authors:  W H Seegers; J F Johnson; C Fell
Journal:  Am J Physiol       Date:  1954-01

10.  Selective necrosis of cardiac and skeletal muscle induced experimentally by means of proteolytic enzyme solutions given intravenously.

Authors:  A KELLNER; T ROBERTSON
Journal:  J Exp Med       Date:  1954-04-01       Impact factor: 14.307
View more
  45 in total

Review 1.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

2.  THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.

Authors:  C HAWKEY; M HOWELL
Journal:  J Clin Pathol       Date:  1964-05       Impact factor: 3.411

3.  THROMBOLYTIC THERAPY.

Authors:  A S DOUGLAS; G P MCNICOL
Journal:  Proc R Soc Med       Date:  1964-07

4.  ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.

Authors:  A P FLETCHER; O BIEDERMAN; D MOORE; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

5.  [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO].

Authors:  J JUERGENS
Journal:  Klin Wochenschr       Date:  1964-06-01

6.  In-vitro and in-vivo studies of a preparation of urokinase.

Authors:  G P MCNICOL; S B GALE; A S DOUGLAS
Journal:  Br Med J       Date:  1963-04-06

7.  [Thromboelastographic studies on the blood clot structure in the Sanarelli-Shwartzman phenomenon].

Authors:  G MULLER-BERGHAUS; H J KRECKE; H G LASCH
Journal:  Klin Wochenschr       Date:  1963-03-01

8.  Treatment of peripheral arterial occlusion by streptokinase perfusion.

Authors:  G P MCNICOL; W REID; W H BAIN; A S DOUGLAS
Journal:  Br Med J       Date:  1963-06-08

9.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.

Authors:  N U BANG; A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

10.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.